Oracle Corporation (ORCL) Unveils Next-Gen Clinical AI Agent to Revolutionize Patient Care with Enhanced AI-Powered Clinical Intelligence and Workflow Automation - InvestingChannel

Oracle Corporation (ORCL) Unveils Next-Gen Clinical AI Agent to Revolutionize Patient Care with Enhanced AI-Powered Clinical Intelligence and Workflow Automation

We recently compiled a list of the 15 AI News You Should Not Miss. In this article, we are going to take a look at where Oracle Corporation (NYSE:ORCL) stands against the other AI stocks.

According to a new report by Bloomberg Intelligence (BI), the generative AI market is set for rapid growth, projected to reach $1.3 trillion within the next decade. The market is expected to expand at a CAGR of 42%, initially fueled by training infrastructure and gradually shifting to inference devices for large language models (LLMs), digital ads, specialized software, and services in the medium to long term. Rising demand for generative AI products could generate an additional $280 billion of new software revenue, driven by specialized assistants, new infrastructure products, and copilots that accelerate coding.

READ ALSO: 10 AI News Investors Should Not Miss and Top 10 Trending AI Stocks in Q4

“The world is poised to see an explosion of growth in the generative AI sector over the next ten years that promises to fundamentally change the way the technology sector operates. The technology is set to become an increasingly essential part of IT spending, ad spending, and cybersecurity as it develops”.

-Mandeep Singh, Senior Technology Analyst at Bloomberg Intelligence

The AI world continues to buzz with recent advancements and breakthroughs. On October 29, Linkedin Corporate Communications announced the launch of their first-ever AI agent called Hiring Assistant, developed to take on a recruiter’s most repetitive tasks so that developers can steer their focus on the most impactful work. The company has also rolled out a new coaching feature in LinkedIn Learning to help learners practice human skills through interactive scenarios using text or voice.

In other news, Securiti, the pioneer in data security, privacy, governance, and compliance, announced on Tuesday that it has integrated Nvidia’s NIM microservices into its Securiti Gencore AI solution, empowering users in industries to easily and quickly build safe, enterprise-grade generative AI systems, copilots and AI agents by utilizing proprietary enterprise data safely in diverse data systems and apps.

Medicine is another area where AI is driving significant breakthroughs. On Tuesday, October 29, Biotech firm Iambic Therapeutics revealed that it has made a breakthrough artificial intelligence model. The model can radically reduce the time and money needed to develop new drugs. Its new AI drug discovery model is called Enchant, with a white paper published revealing how Enchant demonstrates a high degree of accuracy when predicting how well the human body would absorb certain drugs.

Asia is also making strides to take the lead in the AI race. The Korea Advanced Institute of Science & Technology (KAIST) has unveiled a new Artificial Intelligence method to speed quantum calculations. Professor Yong-Hoon Kim’s team from the School of Electrical Engineering has achieved a world-first; succeeding in accelerating calculations for electronic structure in quantum mechanics using a convolutional neural network (CNN) model.

Our Methodology

For this article, we selected AI stocks by combing through news articles, stock analysis, and press releases. These stocks are also popular among hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

A team of IT professionals meticulously crafting a large-scale enterprise performance management system.

Oracle Corporation (NYSE:ORCL)

Number of Hedge Fund Holders: 93

Oracle Corporation (NYSE:ORCL) is an American multinational computer technology company offering products and services that address enterprise information technology environments globally.

On Tuesday, October 29, Oracle Corporation (NYSE:ORCL) revealed that it has developed a new version of its Clinical AI Agent built completely upon the world’s latest generative AI technology. Formerly known as Oracle Health’s Clinical Digital Assistant, the second-generation Clinical AI Agent enhances patient-provider interactions by integrating comprehensive clinical intelligence with a multimodal voice user interface. This allows the automation and unification of a wide range of clinical workflows. By capturing and enriching patient interactions, increasing documentation accuracy, and simplifying decision-making through AI, the Clinical AI Agent enhances the productivity levels of physicians.

The AI Agent is integrated with Oracle Health’s electronic health record, having the capability to provide highly accurate draft notes in multiple languages within minutes. It can also propose clinical follow-up and referrals for the provider to review and approve, synchronizing all the information back to patients’ individual medical records. At the same time, it can extract relevant data from the patient notes to automate coding, as well as generate condition-specific medication history and discharge summaries to deliver rapid insights for clinical decision-making.

“Oracle Health Clinical AI Agent exemplifies the ability of Oracle AI to overcome longstanding industry challenges. From reducing burnout to enhancing patient satisfaction and improving reimbursement processes, the Clinical AI Agent is changing the lives of practitioners and the patients they serve”.

– Seema Verma, Executive Vice President and General Manager, Oracle Health and Life Sciences.

Overall ORCL ranks 8th among the AI stocks investors should not miss. While we acknowledge the potential of ORCL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than ORCL but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

 

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

 

Disclosure: None. This article is originally published at Insider Monkey.

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire